Assessment of the long-term safety and efficacy of erenumab during open-label treatment of subjects with chronic migraine

Authors
Category Primary study
ConferenceJournal of Headache and Pain
Year 2018
This article has no abstract
Epistemonikos ID: b8436cfa085248084c332bb56db64b27a79dd1a4
First added on: Apr 29, 2026